When Health Secretary Robert F. Kennedy Jr. announced sweeping job cuts at his department last month, he said that safety ...

Keeping up with scientific advances and practice changes can be one the biggest challenges in managing a complex disease like multiple sclerosis (MS).

Monument Therapeutics, a precision-neuroscience company focused on the development of innovative treatments for serious central nervous system disorders (CNS), today announced two key leadership ...

Monitoring blood levels of DNA fragments shed by dying tumor cells may accurately predict skin cancer recurrence, a new study shows.

David M. Weiner, MD, Rejoins Chemomab as Interim Chief Medical Officer, Bringing Extensive Biotechnology and Pharmaceutical ...

Dr. Young’s presentation, titled “Applying Principles of FDA’s Project Optimus to Oncology and Non-Oncology Rare Diseases,” will take place on Tuesday, April 24, 2025, at 2:00 p.m. Eastern Time at the ...

Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, Telix, the Company) today announces that its prostate cancer PET[1] imaging agent Illuccix® ...

The Supreme Court has temporarily blocked a federal judge’s order to return a Maryland man with protected legal status who ...

Holt McCallany (Mindhunter) (MacGyver) have been tapped for supporting roles in Clean Hands, the true-life drama from writer-director Jake Allyn on which we were first to report last month. The trio ...

The government has halted production not due to illegal narcotics exports but as part of routine risk-based inspections and compliance checks, Arvind Kumar Sharma, managing director of Aveo Pharma, ...